This document is an FCC Authorization letter from Lepro Innovation INC, dated 2024-12-25. It authorizes Bay Area Compliance Laboratories Corp.(Dongguan) to act on Lepro Innovation INC's behalf in all matters relating to application for Equipment authorization. This includes the signing of all documents pertaining to these matters, ensuring that all actions taken by Bay Area Compliance Laboratory Corp.(Dongguan) on Lepro Innovation INC's behalf have the same effect as their own.
The letter also certifies that Lepro Innovation INC is not subject to a denial of federal benefits, including FCC benefits, as per Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. The authorization remains valid until further written notice from the applicant. The document is signed by Vich Xun, QM Director of Lepro Innovation INC.
Array
(
[0] => Array
(
[url_sha] => 20138793de9f7689d8422a94871b17f242e04de472c3300763fdfc0435f14ea3
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8060202
[href_text] => FCC Agent Authorization Letter
[href_description] => Lepro Innovation INC BG1 Smart LED Bulb 2A3MABG1 2A3MABG1 bg1
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] => application/pdf
[http_filename] => GetApplicationAttachment.html?id=8060202
[http_size] => 21054
[file_sha256] => e66b6ab8271cbc88a0468f29267b7b2f8839b1624b4f10a6126c309e6ddcf3be
[domain] => document.fccid
)
)
Array
(
[file_sha256] => e66b6ab8271cbc88a0468f29267b7b2f8839b1624b4f10a6126c309e6ddcf3be
[cleanFccId] => 2A3MABG1
[title] => FCC Authorization Letter for Lepro Innovation INC
[description] => Agent authorization letter from Lepro Innovation INC authorizing Bay Area Compliance Laboratories to act on its behalf.
[brand_name] => Lepro Innovation INC
[keywords] => []
[intro] =>
This document is an FCC Authorization letter from Lepro Innovation INC, dated 2024-12-25. It authorizes Bay Area Compliance Laboratories Corp.(Dongguan) to act on Lepro Innovation INC's behalf in all matters relating to application for Equipment authorization. This includes the signing of all documents pertaining to these matters, ensuring that all actions taken by Bay Area Compliance Laboratory Corp.(Dongguan) on Lepro Innovation INC's behalf have the same effect as their own.
The letter also certifies that Lepro Innovation INC is not subject to a denial of federal benefits, including FCC benefits, as per Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 862. The authorization remains valid until further written notice from the applicant. The document is signed by Vich Xun, QM Director of Lepro Innovation INC.
)
Array
(
[0] => Array
(
[id] => 8060202
[file_sha256] =>
[applicationId] => TcXa56OtyHBvCLacEq8I8g==
[description] => FCC Agent Authorization Letter
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => Cover Letter(s)
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 21056
[submissionDate] => 2025-02-20 00:00:00
[dateAvailable] => 2025-02-20 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 1
[source] => 0
[fccId] => 2A3MABG1
[cleanFccId] => 2A3MABG1
[exif] => 0
)
)